On June 14, 2017, Western Connecticut Health Network (WCHN) announced its launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.
On June 14, 2017, Western Connecticut Health Network (WCHN) announced their launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.
Led by Richard Frank, MD, director of Clinical Cancer Research for WCHN, the study will research those older than 50 years who have been diagnosed with diabetes in the past year (new-onset). There is an estimated 7-fold increased risk of pancreatic cancer during the 3 years following the diagnosis of diabetes.
Since pancreatic cancer is one of the leading causes of death in the US, with a 5-year survival rate of 8%, the study aims use its link to new-onset diabetes as a starting point.
“We need to start somewhere,” explained Dr Steven Brandwein, a study co-investigator and Western Connecticut Medical Group gastroenterologist. “Our expansive health care network is uniquely positioned to spearhead this type of research, which requires strong collaboration with primary care physician groups, as well as specialists in endocrinology, radiology, gastroenterology, pathology and surgery, all of whom are part of the network family.”
The study will include annual magnetic resonance imaging (MRI) scans of its patients for 3 years. Dr Ronald Lee and Dr James Bauman’s specific MRI protocol will be used in the study, followed by an endoscopic ultrasound on any unusual lesions that could represent the presence of cancer or pre-cancer.
The study also requires blood samples from its participants every 6 months to form a serum biobank that could show a DNA sign of pancreatic cancer. By testing the blood samples in the study, the researchers hope to identify a biomarker that does not yet exist.
“We need to make serious inroads into the early diagnosis and treatment of this disease,” concluded Frank. “We hope this study makes a significant contribution to the field and, in the end, saves lives.”
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More